| The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer G Mirji, A Worth, SA Bhat, M El Sayed, T Kannan, AR Goldman, HY Tang, ... Science immunology 7 (75), eabn0704, 2022 | 161 | 2022 |
| Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer KD Miller, S O’Connor, KA Pniewski, T Kannan, R Acosta, G Mirji, S Papp, ... Nature cancer 4 (10), 1491-1507, 2023 | 52 | 2023 |
| Febrile temperature change modulates CD4 T cell differentiation via a TRPV channel-regulated Notch-dependent pathway D Umar, A Das, S Gupta, S Chattopadhyay, D Sarkar, G Mirji, J Kalia, ... Proceedings of the National Academy of Sciences 117 (36), 22357-22366, 2020 | 34 | 2020 |
| Chicago 2014–30 years of γδ T cells M Bonneville, ZW Chen, J Déchanet-Merville, M Eberl, JJ Fournié, ... Cellular Immunology 296 (1), 3-9, 2015 | 23 | 2015 |
| Risk stratification of T-cell Acute Lymphoblastic Leukemia patients based on gene expression, mutations and copy number variation G Mirji, J Bhat, J Kode, S Banavali, M Sengar, P Khadke, O Sait, ... Leukemia research 45, 33-39, 2016 | 17 | 2016 |
| The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition DC Stieg, JLD Parris, THL Yang, G Mirji, SK Reiser, N Murali, M Werts, ... Cancer Research Communications 3 (7), 1200-1211, 2023 | 2 | 2023 |
| 1306 Prevention of antibiotic-induced dysbiosis in human volunteers by DAV132 and preservation of responsiveness to anti-PD-1 therapy demonstrated by transplantation of human … M Messaoudene, N Saint-Lu, F Sablier-Gallis, S Ferreira, C Le Bescop, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 2 | 2022 |
| Immunophenotype and function define TCRγδ+ T-ALL as a distinct subgroup from TCRαβ+ T-ALL patients G Mirji, S Banavali, M Sengar, SV Chiplunkar Leukemia & Lymphoma 61 (1), 108-117, 2020 | 2 | 2020 |
| Haematacon 2013 (54th Annual Conference of Indian Society of Haematology & Blood Transfusion) AML AML Indian J Hematol Blood Transfus (Oct-Dec 2013) 29 (4), 278-400, 2013 | 1 | 2013 |
| Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer B Murphy, T Miyamoto, BS Manning, G Mirji, A Ugolini, T Kannan, ... Journal of Experimental Medicine 221 (12), e20231967, 2024 | | 2024 |
| Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer B Murphy, T Miyamoto, BS Manning, G Mirji, A Ugolini, T Kannan, ... bioRxiv, 2024 | | 2024 |
| Boosting macrophage-specific BCAA oxidation enhances immune activation within the tumor microenvironment and diminishes tumor growth in pancreatic cancer G Mirji, SA Bhat, Z Schug, BZ Stanger, Z Arany, RS Shinde Cancer Research 84 (6_Supplement), 6627-6627, 2024 | | 2024 |
| A microbiome-produced metabolite drives immunostimulatory macrophages and boosts response to immune checkpoint inhibitors in pancreatic cancer. G Mirji, A Worth, S Bhat, M Sayed, T Kannan, A Goldman, HY Tang, Q Liu, ... CANCER RESEARCH 82 (22), 127-127, 2022 | | 2022 |
| Abstract C023: A microbiome-produced metabolite drives immunostimulatory macrophages and boosts response to immune checkpoint inhibitors in pancreatic cancer G Mirji, A Worth, S Bhat, M Sayed, T Kannan, A Goldman, HY Tang, Q Liu, ... Cancer Research 82 (22_Supplement), C023-C023, 2022 | | 2022 |
| THE MICROBIOME-DERIVED METABOLITE TMAO DRIVES IMMUNE ACTIVATION AND BOOSTS RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN PANCREATIC CANCER G Mirji, A Worth, S Bhat, M El Sayed, T Kannan, A Goldman, HY Tang, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A1358-A1358, 2022 | | 2022 |
| Evaluating immune cells in physiological settings: Studying the neonatal immune landscapes and the effect of fever-range temperatures on T-cell differentiation I Phadke | | 2018 |
| Anti-leukemic activity of gamma delta T cells in T-acute lymphoblastic leukemia patients G Mirji, S Banavali, M Sengar, S Chiplunkar EUROPEAN JOURNAL OF CANCER 54, S66-S66, 2016 | | 2016 |